How to lose visceral fat: A new diet approach proven to help combat and burn belly fat
Visceral fat is also known as belly fat and is found inside your abdominal cavity. Carrying too much visceral fat is extremely harmful for one's health. It's linked to a higher risk of type 2 diabetes, insulin resistance, heart disease and even certain cancers. A popular diet which has gained much notoriety could be key in helping you lose your visceral fat. (Source: Daily Express - Health)
Source: Daily Express - Health - September 18, 2020 Category: Consumer Health News Source Type: news

North Carolina Treasurer Dale Folwell removes insulin costs for members of state health plan
In an update to the health insurance plan for the state's employees, North Carolina State Treasurer Dale Folwell is slashing the cost of insulin for its members. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2020 Category: Pharmaceuticals Authors: Seth Thomas Gulledge Source Type: news

A ferry protein in the pancreas protects it from the stress induced by a high-fat diet
(Tokyo Institute of Technology) Scientists at Tokyo Institute of Technology (Tokyo Tech) have now uncovered a key mechanism by which pancreatic function is maintained in response to a high-fat diet. A protein present in pancreatic insulin-producing cells protects them from damage under the stress induced by a high-fat diet. As the world increases its intake of high-fat foods and as type 2 diabetes incidence rises as a result, this protein could be a novel therapeutic target for type 2 diabetes mellitus. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 16, 2020 Category: Biology Source Type: news

Study: Pesco-Mediterranean Diet May Be Ideal For Heart Health
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p0").init({"mcp":"cbs","width":"100%","height":"100%","video":"4708405","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p0","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 15, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall Source Type: news

Insulin Pumps Used Less in Black Children, Even With Insurance Insulin Pumps Used Less in Black Children, Even With Insurance
Attributed to implicit racial bias, disparities in insulin pump use unrelated to socioeconomic status have persisted over the past 15 years.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - September 10, 2020 Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news

Probiotics may help manage childhood obesity
(European Society of Endocrinology) Probiotics may help children and adolescents with obesity lose weight when taken alongside a calorie-controlled diet, according to a study being presented at e-ECE 2020. The study found that obese children who were put on a calorie-restricted diet and given probiotics Bifidobacterium breve BR03 and Bifidobacterium breve B632, lost more weight and had improved insulin sensitivity compared with children on a diet only. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2020 Category: International Medicine & Public Health Source Type: news

Roger Unger, Endocrinologist and Authority on Diabetes, Dies
The University of Texas Southwestern scientist studied the roles of glucagon and insulin in regulating blood glucose, leading to several successful treatments. (Source: The Scientist)
Source: The Scientist - September 4, 2020 Category: Science Tags: News & Opinion Source Type: news

Can COVID-19 Cause Diabetes?
A new report details the case of a 19-year-old German with asymptomatic COVID-19 infection who ended up hospitalized with a new case of insulin-dependent diabetes. (Source: WebMD Health)
Source: WebMD Health - September 3, 2020 Category: Consumer Health News Source Type: news

Nine US States Cap Insulin Cost, but Activists Will'Fight Harder'Nine US States Cap Insulin Cost, but Activists Will'Fight Harder '
Drug makers and health insurers have not legally challenged state laws capping out-of-pocket insulin costs; still, such attempts to make insulin more affordable only apply to (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - September 3, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

More US States Cap Insulin Cost, but Activists Will'Fight Harder'More US States Cap Insulin Cost, but Activists Will'Fight Harder '
Drug makers and health insurers have not legally challenged state laws capping out-of-pocket insulin costs; still, such attempts to make insulin more affordable only apply to (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - September 3, 2020 Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news

Closed-Loop System Beneficial for Children With T1DM
THURSDAY, Sept. 3, 2020 -- For children with type 1 diabetes, a closed-loop system results in the glucose level being in the target range for more time than with use of a sensor-augmented insulin pump, according to a study published in the Aug. 27... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 3, 2020 Category: Pharmaceuticals Source Type: news

The Covid Vaccine Will Require Billions Of Tiny Glass Vials – And This Italian Billionaire Family Is Making Them
Hundreds of employees donned face masks to work around the clock in three daily shifts, seven days a week – making everything from insulin pen cartridges to miniature glass barrels and — most pressingly — millions of tiny sterile vials, each one smaller than a single fluid ounce, that one day wi... (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 3, 2020 Category: Pharmaceuticals Authors: Giacomo Tognini, Forbes Staff Tags: Billionaires /worlds-billionaires Business /business Manufacturing /manufacturing Innovation /innovation Healthcare /healthcare Daily Cover daily-cover Coronavirus Source Type: news

What Is Intravenous Insulin Therapy?
Title: What Is Intravenous Insulin Therapy?Category: MedicationsCreated: 9/3/2020 12:00:00 AMLast Editorial Review: 9/3/2020 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - September 3, 2020 Category: Endocrinology Source Type: news

How Do You Give Intravenous Insulin Therapy?
Title: How Do You Give Intravenous Insulin Therapy?Category: MedicationsCreated: 9/3/2020 12:00:00 AMLast Editorial Review: 9/3/2020 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - September 3, 2020 Category: Endocrinology Source Type: news

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
(University of Pennsylvania School of Nursing) Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM). The challenges of managing multiple doses of daily insulin administration, blood glucose monitoring, dietary and exercise requirements, can make self-care difficult and complicate outcomes. Adolescents with T1DM often have poorer diabetes outcomes than others, indicating that glucose control is difficult for them to maintain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 3, 2020 Category: International Medicine & Public Health Source Type: news

In Medicare, Insulin Costs More for Patients Who Use Pumps In Medicare, Insulin Costs More for Patients Who Use Pumps
The 50% price differential is an unintended consequence of the 21st Century Cures Act exacerbated by the overall rising cost of insulin.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - September 2, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Researchers find molecular link between liver disease, insulin resistance
Yale researchers have zeroed in on a molecular link between nonalcoholic fatty liver disease and liver insulin resistance in type 2 diabetes. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 2, 2020 Category: Universities & Medical Training Source Type: news

Statin Use is Associated With Insulin Resistance Statin Use is Associated With Insulin Resistance
Statins are commonly used cholesterol-lowering drugs, but might they be linked to an increased incidence of insulin resistance?Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 2, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

FDA OKs New'Artificial Pancreas' Medtronic 770G FDA OKs New'Artificial Pancreas' Medtronic 770G
The hybrid closed-loop MiniMed 770G automated insulin delivery system uses the same technology as the current 670G with added Bluetooth connectivity.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 1, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news

Mylan and Biocon Biologics Announce Launch of Semglee(TM) (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes
Semglee available in vial and pen presentations at a 65% discounted list price, the lowest available for a long-acting insulin glargine on the market HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, Aug. 31, 2020 -- (Healthcare Sales & Market... Biopharmaceuticals, Generics, Product Launch Mylan, Biocon Ltd, Biocon Biologics India, Semglee, diabetes, insulin glargine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2020 Category: Pharmaceuticals Source Type: news

Biocon Biologics launches Semglee, drug to control high blood sugar, in US
To encourage broad patient access to this important medicine, Mylan is offering Semglee at a wholesale acquisition cost (WAC)[1] of $147.98 per package of five (5) 3ml pens and $98.65 per 10ml vial, representing the lowest WAC for any long-acting insulin glargine on the market, said Biocon in a press release. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 31, 2020 Category: Pharmaceuticals Source Type: news

Mayo Clinic Q and A: Diabetes management & amp; illness, COVID risk
Dear Mayo Clinic: Diabetes runs in my family. My mother was diagnosed in her 20s and requires daily insulin. Last month, my 45-year-old sister was diagnosed and is now on medication. My doctor told me I was a pre-diabetic. I am curious how I might be able to reduce my risk for diabetes, especially since [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 27, 2020 Category: Databases & Libraries Source Type: news

' Artificial Pancreas' System Improves Glycemic Control in Kids'Artificial Pancreas' System Improves Glycemic Control in Kids
The first published randomized trial of hybrid closed-loop insulin delivery technology for patients aged 6 to 13 years shows improved time in range compared with a sensor-augmented pump.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - August 26, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Blocking pancreas-attacking nerve signals could prevent Type 1 diabetes, researchers say
Researchers said they might have found a way to prevent people from developing Type 1 diabetes by blocking nerve signals that cause the body's immune system to attack insulin-producing cells in the pancreas. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 26, 2020 Category: Consumer Health News Source Type: news

Breastfeeding may reduce risk of diabetes in women
According to a study published in Diabetes, breastfeeding may reduce the risk of diabetes in women by increasing the insulin sensitivity of organs that supply sugar and fat for milk production.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 26, 2020 Category: Endocrinology Source Type: news

Diabetes Treatment: Medication, Diet, and Insulin
Title: Diabetes Treatment: Medication, Diet, and InsulinCategory: Diseases and ConditionsCreated: 12/5/2006 12:00:00 AMLast Editorial Review: 8/25/2020 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - August 25, 2020 Category: Endocrinology Source Type: news

A gatekeeper against insulin resistance in the brain
(Deutsches Zentrum fuer Diabetesforschung DZD) The brain plays a major role in controlling our blood glucose levels. In type 2 diabetes this glucose metabolism brain control is often dysfunctional. A group of scientists at Helmholtz Zentrum M ü nchen and the German Center for Diabetes Research (DZD) have now shown in the 'Journal of Clinical Investigations' that in men a genetic variant of the gene DUSP8 can increase the risk for T2D by impairing our brain response to the hormone insulin. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 21, 2020 Category: Biology Source Type: news

Gestational diabetes and cardiovascular risk: Mayo Clinic Radio Health Minute
Gestational diabetes happens when a woman's body can't make enough insulin during pregnancy. Most women with gestational diabetes deliver healthy babies; however, there are risks of future complications. Dr. Margaret Dow, shares some of those risks in this Mayo Clinic Radio Health Minute. To listen, click the link below. Gestational diabetes (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 21, 2020 Category: Databases & Libraries Source Type: news

Can Artificial Sweeteners Keep Us From Gaining Weight?
Sugar substitutes may help stave off weight gain, but they have metabolic effects that some experts find concerning. (Source: NYT Health)
Source: NYT Health - August 20, 2020 Category: Consumer Health News Authors: Anahad O ’Connor Tags: Artificial Sweeteners Beverages Weight Obesity Diet and Nutrition Sugar Calories Insulin Sucralose (Artificial Sweetener) Aspartame Children and Childhood Source Type: news

Synthetic cells might improve insulin production for Type 1 diabetes patients
Researchers have generated the first synthetic insulin-producing pancreatic cells capable of evading the immune system in people with Type 1 diabetes, according to an article published Wednesday by the journal Nature. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 19, 2020 Category: Consumer Health News Source Type: news

Insulin-producing pancreatic cells could treat type 1 diabetes
A new study from the Salk Institute found that adding two proteins to the beta-like cells 'turbo-charged' them to produce insulin and kept the immune system from attacking them. (Source: the Mail online | Health)
Source: the Mail online | Health - August 19, 2020 Category: Consumer Health News Source Type: news

How Long Does Insulin Last After Injection?
Title: How Long Does Insulin Last After Injection?Category: MedicationsCreated: 8/19/2020 12:00:00 AMLast Editorial Review: 8/19/2020 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 19, 2020 Category: Drugs & Pharmacology Source Type: news

Lean Mass Lower in Survivors of Pediatric Abdominal, Pelvic Tumors
Survivors also have increased prevalence of insulin resistance, low HDL, and high triglycerides (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 14, 2020 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Internal Medicine, Oncology, Pediatrics, Radiology, Journal, Source Type: news

Medtronic plans to buy connected insulin pen startup Companion Medical
The company's smart insulin pen, dubbed the InPen, is slated to become part of Medtronics diabetes portfolio.   (Source: mobihealthnews)
Source: mobihealthnews - August 11, 2020 Category: Information Technology Source Type: news

Amid COVID-19 pandemic, people with diabetes struggle to get insulin
One in four people with diabetes have rationed supplies to cut the cost of their diabetes care since the start of the pandemic, a survey found. (Source: L.A. Times - Health)
Source: L.A. Times - Health - August 11, 2020 Category: Consumer Health News Authors: Tiffany Wong Source Type: news

Amid COVID-19 pandemic, people with diabetes struggle to get insulin
One in four people with diabetes have rationed supplies to cut the cost of their diabetes care since the start of the pandemic, a survey found. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - August 11, 2020 Category: Science Authors: Tiffany Wong Source Type: news

Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis
This commentary highlights the rapid progress in understanding COVID-19 and its relation to diabetes. Authors state that an important next step will be testing the hypothesis that immediate restoration of basal insulin sufficiency can improve outcomes in COVID-19. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 6, 2020 Category: Consumer Health News Source Type: news

PCOS Associated With a Two-fold Risk of Developing Psoriasis PCOS Associated With a Two-fold Risk of Developing Psoriasis
PCOS is characterized by androgen elevation that can lead to insulin resistance and metabolic syndrome, which have also been associated with an increased risk of psoriasis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 5, 2020 Category: Dermatology Tags: Ob/Gyn & Women ' s Health News Source Type: news

UAB, Southern Research make headway on diabetes drug candidate
The University of Alabama at Birmingham and Southern Research have discovered a new drug candidate that may offer a major advancement for diabetes treatment. The experimental drug, which was tested on cell cultures for both Type 1 and Type 2 diabetes, significantly improved four detrimental characteristics of diabetes, including high blood sugar, elevation in the hormone glucagon that counteracts the effects of insulin, promotes glucose production and increases blood glucose; excessive production… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 4, 2020 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Type 2 diabetes: The drink proven to lower post-meal blood glucose and insulin levels
TYPE 2 diabetes symptoms could include nausea, vomiting, shortness of breath or vision problems. As blood sugar levels rise, so these symptoms could become dangerous. Drinking this popular health drink has been shown to lower a person's blood glucose levels after a meal and could help lower your blood sugar. What is it? (Source: Daily Express - Health)
Source: Daily Express - Health - August 3, 2020 Category: Consumer Health News Source Type: news

Type 2 diabetes: How to lower blood sugar no matter the weather according to expert
TYPE 2 diabetes is a lifelong condition that causes a person's blood sugar level to become too high. Blood sugar levels rise due to a dysfunction in the way insulin, a hormone that regulates high blood sugar, is released. An expert discusses how to keep blood sugar healthy, particularly after temperatures drop. (Source: Daily Express - Health)
Source: Daily Express - Health - July 31, 2020 Category: Consumer Health News Source Type: news

Cost-Sharing Caps for Insulin Would Benefit Youth With T1D
WEDNESDAY, July 29, 2020 -- For privately insured young children and adults with type 1 diabetes, the mean annual out-of-pocket spending on insulin was $494 in 2018, and many would benefit from price caps, according to a research letter published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Column: We all want lower drug prices. Why is that so hard to accomplish?
President Trump's executive orders and a California bill on insulin prices highlight America's go-nowhere approach to healthcare reform. (Source: L.A. Times - Health)
Source: L.A. Times - Health - July 28, 2020 Category: Consumer Health News Authors: David Lazarus Source Type: news

Cost-Sharing Caps Help, but Don't Solve Insulin Price Issue Cost-Sharing Caps Help, but Don't Solve Insulin Price Issue
For 60% and 18% of US patients with type 1 diabetes, out-of-pocket spending would decrease under national $25 and $100 insulin caps, respectively, according to a study of young patients.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 28, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Cost-Sharing Caps for Insulin Pricing
Cost-Sharing Caps Help, But Don't Solve Insulin Price Issue (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 27, 2020 Category: General Medicine Source Type: news

Medications May Drive Postmenopausal Weight Gain Medications May Drive Postmenopausal Weight Gain
Use of weight-promoting medications such as antidepressants, beta-blockers, insulin, and glucocorticosteroids may contribute to postmenopausal abdominal weight gain, data from the Women's Health Initiative indicate.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - July 24, 2020 Category: Psychiatry Tags: Diabetes & Endocrinology News Source Type: news

A Life Full of Meaning
The diabetes camp that gave us hope had an unlikely connection to my father, a former priest who would have delighted in being our guardian angel. (Source: NYT Health)
Source: NYT Health - July 24, 2020 Category: Consumer Health News Authors: Suzanne Travers Tags: Diabetes Camps and Camping Summer (Season) Children and Childhood Insulin Chaplains Source Type: news

Gene in fat plays key role in insulin resistance
(UT Southwestern Medical Center) DALLAS - July 23, 2020 - Deleting a key gene in mice in just their fat made tissues throughout these animals insulin resistant, in addition to other effects, a new study by UT Southwestern researchers shows. The findings, reported in a recent issue of PNAS, could shed light on Type 2 diabetes and other insulin resistance disorders, which remain poorly understood despite decades of study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 23, 2020 Category: International Medicine & Public Health Source Type: news

Cinnamon May Slow Progression To Type 2 Diabetes, Boston Study Finds
(CNN) — Cinnamon may improve blood sugar control in people with a condition known as prediabetes and may slow the progression to type 2 diabetes, according to a new pilot study of 51 people with elevated blood sugars. “We are looking for safe, durable and cost-effective approaches to reduce the progression from prediabetes to type 2 diabetes,” said study author Dr. Giulio Romeo, a staff physician at Boston’s Joslin Diabetes Center and the division of endocrinology at Beth Israel Deaconess Medical Center. The study published Tuesday in the Journal of the Endocrine Society. “Our 12-week study sh...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 21, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Cinnamon CNN Diabetes Source Type: news

Biocon partners with Voluntis to develop digital therapeutics for diabetes patients
The licensing agreement, signed between Biocon Biologics ’ subsidiary Biocon Sdn. Bhd., Malaysia and Voluntis, would make Biocon Biologics one of the first insulin companies to offer a US Food and Drug Administration-cleared and CE-marked, digital therapeutic product - Insulia - to Type 2 diabetes patients, said Biocon in a press release. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2020 Category: Pharmaceuticals Source Type: news